The spleen in myelofibrosis with myeloid metaplasia. 2004

Ayalew Tefferi, and David M Nagorney
Divsion of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.

UI MeSH Term Description Entries
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013156 Splenectomy Surgical procedure involving either partial or entire removal of the spleen. Splenectomies
D013163 Splenomegaly Enlargement of the spleen. Enlarged Spleen,Spleen, Enlarged
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Ayalew Tefferi, and David M Nagorney
January 1956, Lijecnicki vjesnik,
Ayalew Tefferi, and David M Nagorney
March 2004, British journal of haematology,
Ayalew Tefferi, and David M Nagorney
August 2000, The New England journal of medicine,
Ayalew Tefferi, and David M Nagorney
April 2000, The New England journal of medicine,
Ayalew Tefferi, and David M Nagorney
October 2003, Hematology/oncology clinics of North America,
Ayalew Tefferi, and David M Nagorney
May 1970, Revista clinica espanola,
Ayalew Tefferi, and David M Nagorney
January 1986, Blood,
Ayalew Tefferi, and David M Nagorney
August 2000, The New England journal of medicine,
Ayalew Tefferi, and David M Nagorney
February 1959, A.M.A. archives of pathology,
Ayalew Tefferi, and David M Nagorney
August 1973, Blood,
Copied contents to your clipboard!